comparemela.com

Latest Breaking News On - Indv l - Page 1 : comparemela.com

FTSE drops more than 1% after weak US data | 18 February 2021

FTSE 100 slump continues after high inflation figures | 18 February 2021

18 February 2021 | 08:22am StockMarketWire.com - The FTSE 100 opened almost 38 points down at 6,710.90 this morning, continuing its slump from yesterday on the back of higher-than-expected inflation figures. Medical technology company Smith & Nephew fell 6.1% to £14.72 as it reported a 42% fall in trading profits as consequences of the pandemic lead to a decreased revenue across the group as well as lower gross margins. Hays rose 1.2% to 159.9p despite reporting a sharp fall in first-half profit. The recruitment company vowed to resume its dividend payments later this year in August, citing a stronger recovery in the second quarter. Barclays fell 1.5% to 152.1p as profit was hit by £4.8 billion in bad loan provisions.

Indivior swings to annual loss on competition from generic drugs | 18 February 2021

18 February 2021 | 07:43am StockMarketWire.com - Drugmaker Indivior swung to a loss in 2020 as revenue slipped amid competition from generic drugs to treat opioid dependence. For the year ended 31 December, the company reported a pre-tax loss $173 million, compared with a profit of $180 million year-on-year as revenue slipped 39% to $647 million. The loss was driven by exceptional costs of $244 million primarily related to litigation settlements, and a loss of Suboxone film share loss. The company, however, said it has de-risked the business as it works toward the transformational potential of Subloclade. Looking to 2021, the company guided net revenue of $625 million, with Subclocade revenue between $185 million and $210 million and Perseris revenue in a range of $17 million to $20 million.

FTSE 100 in a funk as sentiment turns and sterling advances | 18 February 2021

18 February 2021 | 12:04pm StockMarketWire.com - The FTSE 100 saw losses deepen by lunchtime on Thursday as the positive sentiment from earlier in the week waned and sterling continued to make gains against the dollar and the euro. By midday the index was down 0.8% to 6,654.57 with US futures markets indicating a modest slump when trading resumes later on. Medical technology company Smith & Nephew fell 5.1% to £14.87 as it reported a 42% fall in trading profits as consequences of the pandemic lead to a decreased revenue across the group as well as lower gross margins. Hays dipped 0.1% to 157.8p despite reporting a sharp fall in first-half profit. The recruitment company vowed to resume its dividend payments later this year in August, citing a stronger recovery in the second quarter.

Indivior lifts outlook on profit following stronger revenue of drugs to treat opioid addiction | 15 January 2021

Indivior lifts outlook on profit following stronger revenue of drugs to treat opioid addiction

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.